YU28800A - Use of insulin sensitisers for manufacture of a medicament for the treatment of hyperglycaemia - Google Patents

Use of insulin sensitisers for manufacture of a medicament for the treatment of hyperglycaemia

Info

Publication number
YU28800A
YU28800A YU28800A YU28800A YU28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A YU 28800 A YU28800 A YU 28800A
Authority
YU
Yugoslavia
Prior art keywords
hyperglycaemia
medicament
manufacture
treatment
insulin sensitisers
Prior art date
Application number
YU28800A
Other languages
Serbo-Croatian (sh)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beechem P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechem P.L.C. filed Critical Smithkline Beechem P.L.C.
Publication of YU28800A publication Critical patent/YU28800A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Use of insulin sensitisers for manufacture of a medicament for the treatment of hyperglycaemia. This invention relates of the use of an insulin sensitiser for the manufacture of a medicament for the treatment of hyperglycaemia wherein plasma glucose levels are in the range of from elevated normal to ≤126 mg/dl.
YU28800A 1997-10-13 1998-10-12 Use of insulin sensitisers for manufacture of a medicament for the treatment of hyperglycaemia YU28800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
YU28800A true YU28800A (en) 2003-02-28

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
YU28800A YU28800A (en) 1997-10-13 1998-10-12 Use of insulin sensitisers for manufacture of a medicament for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (en) * 1987-09-04 2000-05-11 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
IL135513A0 (en) 2001-05-20
NO20001898L (en) 2000-06-09
SK5312000A3 (en) 2000-09-12
EA200000419A1 (en) 2000-10-30
HUP0003922A2 (en) 2001-10-28
BG104404A (en) 2000-12-29
NZ503862A (en) 2003-01-31
OA11683A (en) 2005-01-12
TR200000958T2 (en) 2000-08-21
CA2306086A1 (en) 1999-04-22
CN1281359A (en) 2001-01-24
WO1999018943A1 (en) 1999-04-22
EA002659B1 (en) 2002-08-29
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
PL339813A1 (en) 2001-01-02
EP1023056A1 (en) 2000-08-02
BR9815219A (en) 2001-01-02
NO20001898D0 (en) 2000-04-12
JP2001519382A (en) 2001-10-23
AU9547098A (en) 1999-05-03
HUP0003922A3 (en) 2001-12-28
CZ20001297A3 (en) 2001-08-15
KR20010024481A (en) 2001-03-26
ID24521A (en) 2000-07-20
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
MXPA03003870A (en) Combination therapy comprising anti-diabetic and anticonvulsant agents.
EP1537861A3 (en) Use of aminothiol compounds for the treatment xerostomia caused by therapeutic agents or radiation
WO2003068170A3 (en) Enzyme treatment of foodstuffs for celiac sprue
CA2294247A1 (en) Antioxidant enhancement of therapy for hyperproliferative conditions
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
EA200000814A1 (en) PHARMACEUTICAL COMPOSITION TOPIRAMAT
MXPA05007470A (en) Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes.
AP9801174A0 (en) Cyclic sulfone derivatives.
EP2266539A3 (en) Methods of treatment using a gastric retained gabapentin dosage
WO2003096979A3 (en) Drug therapy for celiac sprue
WO1997002046A3 (en) Saccharide conjugates
AU2003234529A1 (en) Glp-1 gene delivery for the treatment of type 2 diabetes
EP1604674A3 (en) Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
CA2253130A1 (en) A medicament for treating obesity and improving lipid metabolism
DE59800935D1 (en) Immuntolerante prothrombinkomplex-präparation
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
EP1007055A4 (en) Methods for the administration of amifostine
AU5372199A (en) Cyclopentabenzofuran derivatives and their use
AU4133400A (en) Cystic fibrosis medicaments
PL323145A1 (en) Transcutaneous therapeutic system (tts) for administering testosterone
AU2787495A (en) Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
YU28800A (en) Use of insulin sensitisers for manufacture of a medicament for the treatment of hyperglycaemia